Zoetis Inc - Ordinary Shares - Class A

NYSE:ZTS  
204.76
+0.05 (+0.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)97.05B
Current PE50.92
Forward PE 44.9
2yr Forward PE 39.76
See more stats
Estimates Current Quarter
Revenue$1.93 Billion
Adjusted EPS$1.12
See more estimates
10-Day MA$203.16
50-Day MA$203.36
200-Day MA$176.33
See more pivots

Zoetis Inc - Ordinary Shares - Class A Stock, NYSE:ZTS

10 Sylvan Way, 10 Sylvan Way, Parsippany, New Jersey 07054
Phone: +1.973.822.7000
Number of Employees: 11300

Description

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.